AIM Signs Landmark 5-Year Deal with Central European Media Enterprises (CME)
Globenewswire -
OCALA, Fla., Feb. 17, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), an immuno-pharma company focused on the...